{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-096914","form_type":"8-K","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.697134+00:00","generated_at":"2026-05-18T05:50:45.382998+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"FibroBiologics converts $1.4M of notes, issues 2.15M shares at ~$0.65 avg price","bullets":["On June 20-27 and July 15, 2025, YA II PN converted $1.4M of Second and Third Notes into 2,154,530 common shares.","Conversion prices ranged from $0.5624 to $0.6934 per share; Second Note fully converted, Third Note has $3.9M remaining.","First Note retains full $5.0M principal; total remaining note balance across all three is $8.9M.","Shares issued in reliance on Section 4(a)(2) exemption; no public offering involved."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-096914","json":"https://secwatch.observer/filing/0000950170-25-096914.json","markdown":"https://secwatch.observer/filing/0000950170-25-096914.md","text":"https://secwatch.observer/filing/0000950170-25-096914.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000095017025096914/0000950170-25-096914-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000095017025096914/fblg-20250620.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:50:45.382998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}